Buchumschlag

Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in Germany

Novel pharmaceutical treatments reducing cardiovascular events in dyslipidaemia patients must demonstrate clinical efficacy and cost-effectiveness to promote long-term adoption by patients, physicians, and insurers.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Michaeli, Daniel (VerfasserIn) , Michaeli, Julia (VerfasserIn) , Boch, Tobias (VerfasserIn) , Michaeli, Christoph T. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2023
In: Cardiovascular drugs and therapy
Year: 2023, Jahrgang: 37, Heft: 4, Pages: 683-694
ISSN:1573-7241
DOI:10.1007/s10557-021-07310-y
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10557-021-07310-y
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s10557-021-07310-y
Volltext
Verfasserangaben:Daniel Tobias Michaeli, Julia Caroline Michaeli, Tobias Boch, Thomas Michaeli

MARC

LEADER 00000caa a2200000 c 4500
001 1894689828
003 DE-627
005 20241205150803.0
007 cr uuu---uuuuu
008 240709s2023 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10557-021-07310-y  |2 doi 
035 |a (DE-627)1894689828 
035 |a (DE-599)KXP1894689828 
035 |a (OCoLC)1475301840 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Michaeli, Daniel  |d 1997-  |e VerfasserIn  |0 (DE-588)1277183244  |0 (DE-627)1830345109  |4 aut 
245 1 0 |a Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in Germany  |c Daniel Tobias Michaeli, Julia Caroline Michaeli, Tobias Boch, Thomas Michaeli 
264 1 |c August 2023 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 11. Januar 2022 
500 |a Gesehen am 09.07.2024 
520 |a Novel pharmaceutical treatments reducing cardiovascular events in dyslipidaemia patients must demonstrate clinical efficacy and cost-effectiveness to promote long-term adoption by patients, physicians, and insurers. 
650 4 |a Cost-effectiveness 
650 4 |a Ezetimibe 
650 4 |a Icosapent ethyl 
650 4 |a PCSK9 inhibitors 
650 4 |a Statin 
700 1 |a Michaeli, Julia  |d 1996-  |e VerfasserIn  |0 (DE-588)127911424X  |0 (DE-627)1832296377  |4 aut 
700 1 |a Boch, Tobias  |d 1984-  |e VerfasserIn  |0 (DE-588)1052922015  |0 (DE-627)789313847  |0 (DE-576)40866732X  |4 aut 
700 1 |a Michaeli, Christoph T.  |d 1992-  |e VerfasserIn  |0 (DE-588)1277182337  |0 (DE-627)1830343769  |4 aut 
773 0 8 |i Enthalten in  |t Cardiovascular drugs and therapy  |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1987  |g 37(2023), 4 vom: Aug., Seite 683-694  |h Online-Ressource  |w (DE-627)320429237  |w (DE-600)2003553-6  |w (DE-576)106890727  |x 1573-7241  |7 nnas  |a Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in Germany 
773 1 8 |g volume:37  |g year:2023  |g number:4  |g month:08  |g pages:683-694  |g extent:12  |a Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in Germany 
856 4 0 |u https://doi.org/10.1007/s10557-021-07310-y  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s10557-021-07310-y  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240709 
993 |a Article 
994 |a 2023 
998 |g 1277182337  |a Michaeli, Christoph T.  |m 1277182337:Michaeli, Christoph T.  |d 60000  |d 61400  |e 60000PM1277182337  |e 61400PM1277182337  |k 0/60000/  |k 1/60000/61400/  |p 4  |y j 
998 |g 1052922015  |a Boch, Tobias  |m 1052922015:Boch, Tobias  |d 60000  |d 61200  |e 60000PB1052922015  |e 61200PB1052922015  |k 0/60000/  |k 1/60000/61200/  |p 3 
998 |g 127911424X  |a Michaeli, Julia  |m 127911424X:Michaeli, Julia  |d 60000  |e 60000PM127911424X  |k 0/60000/  |p 2 
998 |g 1277183244  |a Michaeli, Daniel  |m 1277183244:Michaeli, Daniel  |d 910000  |d 910100  |e 910000PM1277183244  |e 910100PM1277183244  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1894689828  |e 4548236066 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in Germany","title":"Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in Germany"}],"person":[{"role":"aut","family":"Michaeli","given":"Daniel","display":"Michaeli, Daniel"},{"role":"aut","display":"Michaeli, Julia","given":"Julia","family":"Michaeli"},{"family":"Boch","given":"Tobias","display":"Boch, Tobias","role":"aut"},{"display":"Michaeli, Christoph T.","given":"Christoph T.","family":"Michaeli","role":"aut"}],"origin":[{"dateIssuedDisp":"August 2023","dateIssuedKey":"2023"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online veröffentlicht: 11. Januar 2022","Gesehen am 09.07.2024"],"id":{"eki":["1894689828"],"doi":["10.1007/s10557-021-07310-y"]},"recId":"1894689828","name":{"displayForm":["Daniel Tobias Michaeli, Julia Caroline Michaeli, Tobias Boch, Thomas Michaeli"]},"relHost":[{"note":["Gesehen am 05.12.05","Ungezählte Beil.: Suppl"],"pubHistory":["1.1987/88 -"],"title":[{"title":"Cardiovascular drugs and therapy","title_sort":"Cardiovascular drugs and therapy","subtitle":"CDT"}],"origin":[{"dateIssuedKey":"1987","publisher":"Springer Science + Business Media B.V ; Kluwer","dateIssuedDisp":"1987-","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"CDT"}],"part":{"extent":"12","volume":"37","pages":"683-694","text":"37(2023), 4 vom: Aug., Seite 683-694","year":"2023","issue":"4"},"disp":"Cost-effectiveness of lipid-lowering therapies for cardiovascular prevention in GermanyCardiovascular drugs and therapy","physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"id":{"eki":["320429237"],"zdb":["2003553-6"],"issn":["1573-7241"]},"recId":"320429237"}],"physDesc":[{"extent":"12 S."}],"language":["eng"]} 
SRT |a MICHAELIDACOSTEFFECT2023 

Ähnliche Einträge